Full-Time

Manager Quality Complaints

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Senior, Expert

Hyderabad, Telangana, India

Category
Public Health
Biology & Biotech
Requirements
  • Doctorate degree OR
  • Master’s degree and 4 to 6 years of quality management, with focus on complaints handling experience OR
  • Bachelor’s degree and 6 to 8 years of quality management, with focus on complaints handling experience OR
  • Diploma and 10 to 12 years of quality management, with focus on complaints handling experience
Responsibilities
  • Ensures execution of the quality complaint process in compliance with the applicable procedures, laws and regulations
  • Ensures quality of tasks and complaint records
  • Leads team initiatives/projects
  • Establishes performance expectations and monitors for daily improvement
  • Prioritizes workload as needed based on the changing incoming volumes or records
  • Leads and mentors a team of complaint investigators, providing mentorship and support as needed
  • Raises potential quality issues to management
  • Monitors team's performance and oversight of staff's performance and development
  • Assures training is continuously maintained
  • Accountable for day-to-day operations of the staff members under their supervision
  • Participates in audits and assessments as required, providing documentation and information on complaint management processes
  • Develops a culture of continuous improvement and customer-centricity within the team
Desired Qualifications
  • Quality and manufacturing experience in biotech, medical device or pharmaceutical industry
  • Leadership skills and the ability to supervise multiple projects simultaneously
  • Familiarity with advance project management tools
  • Ability to operate in a matrixed or team environment with site, functional, and executive leadership
  • Experience in driving decision making by using DAI principles
  • Understanding of quality and industry requirements/expectations of a QMS
  • Understanding of the applicable manufacturing/testing processes (i.e., API, Drug Substance, Drug Product, Packaging, Device manufacturing processes)
  • Ability to negotiate a strategic position after taking feedback from multiple sources
  • Proven ability to lead cross-functional teams, consistently deliver timely, and high-quality results
  • Build rapport with customers and colleagues to develop a collaborative environment.
  • Ability to handling disagreements and finding resolutions that satisfy both parties.
  • Adjust strategies and approaches based on the specifics of each complaint. Ability to work optimally with global, virtual teams.
  • Grasp reputability and steering through regulatory guidelines and compliance obligations.
  • View issues from the customer's perspective to better understand their concerns.
  • Ability to travel +/- 20% of time to domestic and international Amgen sites

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are medicines made from living organisms. These therapies target conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen stands out from competitors by reinvesting a large portion of its earnings into research and development, ensuring a strong pipeline of new treatments. The goal of Amgen is to improve patient care and address critical health challenges through its innovative therapeutic solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Amgen's investment in AI aligns with trends in biotechnology innovation.
  • Institutional investments indicate strong market confidence in Amgen's growth.
  • FTC clearance of the Horizon merger may ease future regulatory hurdles.

What critics are saying

  • Competitors' AI-driven drug discovery could outpace Amgen's traditional R&D methods.
  • FTC scrutiny of mergers may complicate Amgen's future growth strategy.
  • Advancements in quantum technologies could pose a competitive threat to Amgen.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline of potential new therapies in development.
  • Amgen's acquisition of Horizon Therapeutics enhances its rare disease portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.

BioSpace
Sep 19th, 2023
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans

The consent agreement struck between the FTC and Amgen and Horizon Therapeutics could have significant implications for ongoing and future M&A challenges, experts told BioSpace.